Sorafenib: The gold standard therapy in advanced hepatocellular carcinoma and beyond

“It is likely that the development of new drugs acting on the RAS/RAF/MEK/ERK signaling pathway and the receptor crosstalk mechanisms may lead to a further improvement in the overall survival of patients with advanced hepatocellular carcinoma.”